Virtus Investment Advisers’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Virtus Investment Advisers's HALO Position: Q2 2026 in Review
Virtus Investment Advisers increased its Halozyme (HALO) stake by 23% in Q2 2026, buying an estimated $216K and bringing the position to 16,732 shares worth $1.31M. The position accounts for 0.31% of the portfolio, ranked #149.
Virtus Investment Advisers first reported a position in HALO in Q3 2022 and has held it in 16 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Virtus Investment Advisers held 16,732 shares of Halozyme worth $1.31M as of Q2 2026.
- Virtus Investment Advisers bought 3,161 Halozyme shares in Q2 2026, an estimated $216K.
- Halozyme made up 0.31% of Virtus Investment Advisers's portfolio in Q2 2026, its #149 holding.
- Virtus Investment Advisers first reported a position in Halozyme in Q3 2022 and has held it in 16 quarters since.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.